Bas van de Kar
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Melanoma and MAPK Pathways 3
- Enzyme function and inhibition 2
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Tjeerd Barf (10 shared papers)Allard Kaptein (10 shared papers)Michael Gulrajani (5 shared papers)Todd Covey (5 shared papers)Dennis Demont (6 shared papers)Diana Mittag (3 shared papers)Edwin de Zwart (6 shared papers)Bart van Lith (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Organic & Biomolecular Chemistry (1 paper)Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Bas van de Kar
10 papers receiving 451 citations
Peers
Comparison fields: 5 of 44
- Genetics 325
- Pathology and Forensic Medicine 240
- Hematology 129
- Immunology 90
- Gastroenterology 18
Countries citing papers authored by Bas van de Kar
This map shows the geographic impact of Bas van de Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas van de Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas van de Kar more than expected).
Fields of papers citing papers by Bas van de Kar
This network shows the impact of papers produced by Bas van de Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas van de Kar. The network helps show where Bas van de Kar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bas van de Kar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 272 | |
| 2 | 2018 | 71 | |
| 3 | 2015 | 36 | |
| 4 | 2015 | 24 | |
| 5 | 2011 | 19 | |
| 6 | 2011 | 17 | |
| 7 | 2011 | 13 | |
| 8 | 2020 | 7 | |
| 9 | 2021 | 2 | |
| 10 | 2019 | 1 |
About Bas van de Kar
Bas van de Kar is a scholar working on Molecular Biology, Genetics, Pathology and Forensic Medicine, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 462 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Melanoma and MAPK Pathways (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Enzyme function and inhibition (2 papers), Synthesis and biological activity (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Quinazolinone synthesis and applications (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Genetics (325 citations), Pathology and Forensic Medicine (240 citations), Hematology (129 citations), Immunology (90 citations) and Gastroenterology (18 citations). Bas van de Kar has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Tjeerd Barf, Allard Kaptein, Michael Gulrajani, Todd Covey, Dennis Demont, Diana Mittag, Edwin de Zwart, Bart van Lith, Fanny Krantz and Raquel Izumi. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Organic & Biomolecular Chemistry, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.